Description

2-[2-(Dimethylamino)Ethyl]-3,4-Dihydro-4-Methylpyrido[3,2-F][1,4]Oxazepine-5(2H)-Thione/(E)-2-Butenedioic Acid,(1:X) is a high-purity, complex heterocyclic salt compound of significant interest in advanced pharmaceutical research and development. This compound serves as a critical intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents, particularly those targeting the central nervous system. It is primarily required by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in developing next-generation medications.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel psychotropic and neurological drugs.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core structure for potential APIs targeting specific receptors.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize drug efficacy and safety profiles.
• Preclinical Studies: Employed in the formulation of compounds for pharmacological and toxicological testing.
• Reference Standard: Acts as a high-purity analytical standard for quality control and regulatory submissions.
• Process Chemistry: Utilized in scaling up synthetic routes from laboratory to pilot plant scale.

Basic Information

Product Name	2-[2-(Dimethylamino)Ethyl]-3,4-Dihydro-4-Methylpyrido[3,2-F][1,4]Oxazepine-5(2H)-Thione/(E)-2-Butenedioic Acid,(1:X)
CAS No.	115609-60-4
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	2-[2-(Dimethylamino)ethyl]-3,4-dihydro-4-methylpyrido[3,2-f][1,4]oxazepine-5(2H)-thione fumarate (1:1); 4-Methyl-2-[2-(dimethylamino)ethyl]-2,3-dihydro-5H-pyrido[3,2-f][1,4]oxazepine-5-thione fumarate; Fumaric acid salt of 2-[2-(dimethylamino)ethyl]-4-methyl-2,3-dihydro-5H-pyrido[3,2-f][1,4]oxazepine-5-thione; (E)-2-Butenedioic acid compound with 2-[2-(dimethylamino)ethyl]-4-methyl-2,3-dihydro-5H-pyrido[3,2-f][1,4]oxazepine-5-thione (1:1); 115609-60-4; Pyridooxazepine-thione fumarate derivative
EINECS	Contact for details

Quality Control

Our 2-[2-(Dimethylamino)Ethyl]-3,4-Dihydro-4-Methylpyrido[3,2-F][1,4]Oxazepine-5(2H)-Thione/(E)-2-Butenedioic Acid,(1:X) is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.